<DOC>
	<DOCNO>NCT00004317</DOCNO>
	<brief_summary>RATIONALE : Congenital toxoplasmosis infection cause parasitic organism Toxoplasma gondii , may pass infect mother unborn child . The mother may mild symptom symptom ; fetus , however , may experience damage eye , nervous system , skin , ear . The newborn may low birth weight , enlarge liver spleen , jaundice , anemia , petechia , eye damage . Giving antiparasitic drug pyrimethamine sulfadiazine standard treatment congenital toxoplasmosis , yet know regimen pyrimethamine effective disease . PURPOSE : Randomized phase IV trial determine regimen pyrimethamine effective combine sulfadiazine leucovorin treat patient congenital toxoplasmosis .</brief_summary>
	<brief_title>Pyrimethamine , Sulfadiazine , Leucovorin Treating Patients With Congenital Toxoplasmosis</brief_title>
	<detailed_description>PROTOCOL OUTLINE : Infants randomly assign 1 2 treatment group . Patients stratify disease severity , chorioretinitis , prenatal treatment , certainty diagnosis birth . One group infant treat load dose oral pyrimethamine follow high dose first two month low dose remainder 12 month . Sulfadiazine leucovorin calcium also give orally 12 month . The pyrimethamine load dose omit prior prenatal therapy give . Another group infants treat high dose oral pyrimethamine first 6 month low dose remainder 12 month . Sulfadiazine leucovorin calcium administer concurrently . Infected fetus pregnant woman nonrandomly assign treatment pyrimethamine , sulfadiazine , leucovorin calcium first trimester . Spiramycin administer fetal diagnosis make . Concurrent prednisone active retinal inflammation elevate cerebrospinal fluid protein allow . Collaborating physician also refer historical control , treat first year life receive one month less therapy , old one year . Absence treatment first year life due parental preference , prior inadequate follow-up family physician , lack detection treatment eye disease age one year otherwise asymptomatic child . These historical , untreated patient ( enter study old one year ) compare treated child randomize study . These historical patient randomize . Any abnormality require treatment ( e.g. , active chorioretinitis ) child ( include historical patient ) treat . All infant follow birth , age 1 , 3.5 , 5 , 7.5 , 10 , 15 , 20 .</detailed_description>
	<mesh_term>Toxoplasmosis</mesh_term>
	<mesh_term>Toxoplasmosis , Congenital</mesh_term>
	<mesh_term>Calcium , Dietary</mesh_term>
	<mesh_term>Levoleucovorin</mesh_term>
	<mesh_term>Leucovorin</mesh_term>
	<mesh_term>Pyrimethamine</mesh_term>
	<mesh_term>Sulfadiazine</mesh_term>
	<mesh_term>Spiramycin</mesh_term>
	<criteria>PROTOCOL ENTRY CRITERIA : Infants congenital toxoplasmosis Toxoplasma gondii confirm prior age 2.5 month Pregnant woman evidence toxoplasma infection clinical observation amniotic fluid sample Acute infection acquire gestation evidence fetal infection Untreated old child enter control Asymptomatic congenital toxoplasmosis Age 1 year No treatment within first year life No 1 month prior therapy</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2009</verification_date>
	<keyword>immunologic disorder infectious disorder</keyword>
	<keyword>rare disease</keyword>
	<keyword>toxoplasmosis</keyword>
</DOC>